Alternatively, binding of KYN to AHR increases PD‐1 expression on tumour‐specific CD8+ T cells and induces differentiation and activation of immunosuppressive Tregs and facilitates the recruitment of tolerogenic myeloid cells.161. Here, CD8A is linked to neoplasm.